Integral Investment Advisors Inc. Has $513,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Integral Investment Advisors Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,015 shares of the healthcare conglomerate’s stock after purchasing an additional 34 shares during the quarter. Integral Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $513,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Jmac Enterprises LLC grew its position in shares of UnitedHealth Group by 2.2% in the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after buying an additional 18 shares during the period. Wallace Capital Management Inc. grew its position in shares of UnitedHealth Group by 0.9% in the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after buying an additional 19 shares during the period. Western Pacific Wealth Management LP grew its position in shares of UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after buying an additional 19 shares during the period. JNBA Financial Advisors grew its position in shares of UnitedHealth Group by 0.4% in the 3rd quarter. JNBA Financial Advisors now owns 4,686 shares of the healthcare conglomerate’s stock worth $2,740,000 after buying an additional 20 shares during the period. Finally, Paragon Capital Management LLC grew its position in shares of UnitedHealth Group by 2.9% in the 3rd quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate’s stock worth $422,000 after buying an additional 20 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by insiders.

Analysts Set New Price Targets

UNH has been the topic of several recent analyst reports. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Oppenheimer increased their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. KeyCorp reissued an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial cut their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Down 7.3 %

UNH stock opened at $465.58 on Friday. The firm has a fifty day moving average price of $519.27 and a 200 day moving average price of $560.48. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market cap of $428.46 billion, a PE ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $5.83 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.